Can a company proactively notify a patient organisation of recruiting clinical trials? Does this depend on the phase of the study?

The Code does not prohibit companies notifying patient organisations about clinical research projects. The purpose of such notification needs to be considered. The European Federation of Pharmaceutical Industries and Associations (EFPIA) publication 'Working Together with Patient Groups' provides some additional information,